Papers: 20 Dec 2014 - 27 Dec 2014
Bilirubin-induced neural impairment: A special focus on myelination, age-related windows of susceptibility and associated co-morbidities.
Comparison between balanced steady-state free precession and standard spoiled gradient echo magnetization transfer ratio imaging in multiple sclerosis: methodical and clinical considerations.
Role of Glycine N-methyltransferase in The Regulation of T Cell Responses in Experimental Autoimmune Encephalomyelitis.
Decreased urinary level of melatonin as a marker of disease severity in patients with multiple sclerosis.
Neurological disability and its association with walking impairment in multiple sclerosis: brief review.
Interleukin-34 restores blood-brain barrier integrity by upregulating tight junction proteins in endothelial cells.
Seroprevalence of NMO-IgG Antibody in Neuromyelitis optica (NMO) and Its Specificity in Differentiating NMO from Other Demyelinating Diseases with Overlap Symptoms: An Iranian Experience.
Vitamin D is associated with degree of disability in patients with fully ambulatory relapsing-remitting multiple sclerosis.
Glatiramer acetate (GA) prevents TNF-α-induced monocyte adhesion to primary endothelial cells through interfering with the NF-κB pathway.
TIP30 inhibits oligodendrocyte precursor cell differentiation via cytoplasmic sequestration of Olig1.
Anxiety in patients with multiple sclerosis: association with disability, depression, disease type and sex.
Role of thalamic diffusion for disease differentiation between multiple sclerosis and ischemic cerebral small vessel disease.
Temporal Hierarchical Adaptive Texture CRF for Automatic Detection of Gadolinium-Enhancing Multiple Sclerosis Lesions in Brain MRI.
A natural flavonoid glucoside icariin inhibits Th1 and Th17 cell differentiation and ameliorates experimental autoimmune encephalomyelitis.
Managing psychological stress in the multiple sclerosis medical visit: Patient perspectives and unmet needs.
A randomised controlled trial of an exercise plus behaviour change intervention in people with multiple sclerosis: the step it up study protocol.
Effects of Physical Exercise on Neuroinflammation, Neuroplasticity, Neurodegeneration, and Behavior: What We Can Learn From Animal Models in Clinical Settings.
Cost-Effectiveness Analysis of OnabotulinumtoxinA (BOTOX(®)) for the Management of Urinary Incontinence in Adults with Neurogenic Detrusor Overactivity: A UK Perspective.
Comparison of clinical characteristics between neuromyelitis optica spectrum disorders with and without spinal cord atrophy.
Quantification of Global Cerebral Atrophy in Multiple Sclerosis from 3T MRI Using SPM: The Role of Misclassification Errors.
Transgenic replacement of Cx32 in gap junction deficient oligodendrocytes rescues the phenotype of a hypomyelinating leukodystrophy model.
Profile of Differential Promoter Activity by Nucleotide Substitution at GWAS Signals For Multiple Sclerosis.
Pharmacogenomics of interferon-β in multiple sclerosis: What has been accomplished and how can we ensure future progress?
RORγt-specific transcriptional interactomic inhibition suppresses autoimmunity associated with TH17 cells.
Treatment adherence and other patient-reported outcomes as cost determinants in multiple sclerosis: a review of the literature.